<!DOCTYPE html>
<html lang="en" dir="ltr">
	<head>
		<link rel="profile" href="http://www.w3.org/1999/xhtml/vocab" />
		<meta http-equiv="X-UA-Compatible" content="IE=edge">
		<meta charset="utf-8">
		<meta name="viewport" content="width=device-width, initial-scale=1.0">
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="icon" href="/misc/favicon.ico" type="image/x-icon" />
<link rel="canonical" href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Toxicology/CFS_tox_info_tech.html" />
<link rel="shortcut icon" href="/misc/favicon.ico" type="image/x-icon" />
		<title>CFS - TIS - Toxicology Information Sheet | Ministry of the Solicitor General</title>
		<style>
@import url("/modules/system/system.base.css?");
</style>
<style>
@import url("/sites/all/themes/mcscs_jts/css/bootstrap.min.v1.css?");
@import url("/sites/all/themes/mcscs_jts/css/style_v1.css?");
</style>
<style media="print">
@import url("/sites/all/themes/mcscs_jts/css/print.css?");
</style>
		<!-- HTML5 element support for IE6-8 -->
		<!--[if lt IE 9]>
			<script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
		<![endif]-->
		<script src="/sites/all/modules/jquery_update/replace/jquery/1.10/jquery.min.js?v=1.10.2"></script>
<script src="/misc/jquery.once.js?v=1.2"></script>
<script src="/misc/drupal.js?"></script>
<script src="/sites/all/themes/mcscs_jts/js/bootstrap.min.js?"></script>
<script src="/sites/all/themes/mcscs_jts/js/mcscs_custom.js?"></script>
<script>jQuery.extend(Drupal.settings, {"basePath":"\/","pathPrefix":"english\/","ajaxPageState":{"theme":"mcscs_jts","theme_token":"3fLDTG4iRBxuVxWRycmcKwccJ2r_9kJuYFOmNxz81Fk","js":{"sites\/all\/themes\/bootstrap\/js\/bootstrap.js":1,"sites\/all\/modules\/jquery_update\/replace\/jquery\/1.10\/jquery.min.js":1,"misc\/jquery.once.js":1,"misc\/drupal.js":1,"sites\/all\/themes\/mcscs_jts\/js\/bootstrap.min.js":1,"sites\/all\/themes\/mcscs_jts\/js\/mcscs_custom.js":1},"css":{"modules\/system\/system.base.css":1,"sites\/all\/themes\/mcscs_jts\/css\/bootstrap.min.v1.css":1,"sites\/all\/themes\/mcscs_jts\/css\/style_v1.css":1,"sites\/all\/themes\/mcscs_jts\/css\/print.css":1}},"bootstrap":{"anchorsFix":"0","anchorsSmoothScrolling":"0","formHasError":1,"popoverEnabled":0,"popoverOptions":{"animation":1,"html":0,"placement":"right","selector":"","trigger":"click","triggerAutoclose":1,"title":"","content":"","delay":0,"container":"body"},"tooltipEnabled":0,"tooltipOptions":{"animation":1,"html":0,"placement":"auto left","selector":"","trigger":"hover focus","delay":0,"container":"body"}}});</script>
		<!--google analytics script file-->
		<script type="text/javascript" src="https://www.webservices.gov.on.ca/downloads.js"></script>
	</head>
	<body role="document" class="html not-front not-logged-in one-sidebar sidebar-first page-node page-node- page-node-17057 node-type-page i18n-en">
		<div id="skip-link">
			<a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
		</div>
				<header>
<button onclick="topFunction()" id="goToTop" title="Go to Top">Top</button>
	<div class="container mg-top">
		<div class="row">
			<div class="col-md-8">
				<a href="http://www.ontario.ca/en/residents/index.htm" title="Link to Ontario.ca"><img src="/sites/all/themes/mcscs_jts/image/logo-ontario-blk@2x.png" alt="Government of Ontario"></a>
			</div>
							<div class="col-md-4 mcscs-language text-right bold">
					  <div class="region region-site-language">
    <section id="block-locale-language-content" class="block block-locale clearfix">
	<div class="item-list"><ul class="language-switcher-locale-url" id="gc-bar"><li class="first"><a href="http://www.ontario.ca">Ontario.ca</a></li>
<li class="last">Français</li>
</ul></div></section>  </div>
				</div>
					</div>
	</div>
	<div class="container">
		<div class="row">
			<div id="wb-sttl" class="col-md-12">
									<div id="site-name-en">
						Ministry of the<br />Solicitor General
					</div>
				
			</div>
		</div>
		<div class="row">
			<div class="col-md-12">
				<div class="mcscs-arc">
					<div class="col-md-push-6 col-md-6 text-right">
						<form id="search" name="search" method="get" action="http://find.gov.on.ca">
							<input type="hidden" value="simple" name="searchType">
							<input type="hidden" value="mcscs" name="owner">
							<input type="hidden" value="http://www.mcscs.jus.gov.on.ca" name="url">
							<input type="hidden" value="" name="collection">
							<input type="hidden" value="0" name="offset">
							<input type="hidden" value="en" name="lang">
							<input type="hidden" value="ANY" name="type">
							<label id="lblsearchbox" for="searchBox">Search</label>
							<input id="searchBox" name="q" type="text" onfocus="this.value=''" value="Search" title="Search">
							<input id="submit" name="search" type="image" src="/sites/all/themes/mcscs_jts/image/button-search.gif" alt="Search">
						    <div class="navbar-header navbar-default navbar-static-top" id="smrp">
							<button type="button" class=" btn btn-primary dropdown-toggle" id="showmenu-response" aria-expanded="false" data-toggle="collapse" data-target="#myNavbar">
							   <span class="sr-only">Toggle navigation</span>
							   <span class="icon-bar"></span> Menu							</button>
							</div>
						</form>
					</div>
				</div>
			</div>
		</div>
		<nav id="mcscs-sm">
			<div class="row top-nav">
				<div class="col-md-12 text-center">
					<div id="myNavbar" class="collapse navbar-collapse" >						
				    </div>					
																		  <div class="region region-top-menu">
    <section id="block-menu-menu-top-menu" class="block block-menu clearfix">
	<ul class="menu nav"><li class="first leaf"><a href="/english/default.html">Home</a></li>
<li class="leaf"><a href="https://news.ontario.ca/mcscs/en">NewsRoom</a></li>
<li class="leaf"><a href="/english/about_min/mandate.html">About the Ministry</a></li>
<li class="last leaf"><a href="/english/contact_us/contact_us.aspx">Contact Us</a></li>
</ul></section>  </div>
															</div>
			</div>
		</nav>
	</div>
</header>
<div class="main-container container">
			<div id="mcscs-breadcrumbs" class="row">
		<div class="col-md-12">
			<div class="breadcrumb">You are here > <a class="active-trail" href="/english/default.html">Home</a> > <a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/CFS_tech_sheets.html">...</a> > <a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Toxicology/CFS_tox_tech.html">Toxicology</a> > CFS - TIS - Toxicology Information Sheet</div>		</div>
	</div>
		<div class="row">
		<div class="col-md-9 col-md-push-3">
			<section>
				<main>
					<a name="main-content" id="main-content" tabindex="0"></a>
																<h1 class="page-header sr-only">CFS - TIS - Toxicology Information Sheet</h1>
																																																													<div class="content-wrapper">
													<div class="row">
								<div class="col-md-12">
									<ul id="pageActions">
										<li class="print"><a onclick="window.print();return false;" href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Toxicology/CFS_tox_info_tech.html">Print</a></li>
									</ul>
								</div>
							</div>
														  <div class="region region-content">
    <section id="block-system-main" class="block block-system clearfix">
	<div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><style type="text/css">
<!--/*--><![CDATA[/* ><!--*/
h1 img {
width: 100%
}
.heading-bg {
 background-color: rgba(217,217,217,1);
  padding: 4px;
  border-top: 2px solid #a6a6a6;
  border-bottom: 2px solid #a6a6a6;
}
h2 {
font-size: 125%;
}
h3 {
font-size: 115%;
}

/*--><!]]>*/
</style>
<h1><img alt="Centre of Forensic Sciences" src="/sites/default/files/content/mcscs/images/CFS_Banner.png" />
</h1>
<h2 class="h2 heading-bg">Technical Information Sheets
</h2>
<h3 class="h3">Toxicology
</h3>
<hr />
<p class="normal"><a href="/sites/default/files/content/mcscs/docs/Toxicology%20InformationDecember%202020.pdf"><strong>Toxicology – PDF, 285 kb</strong></a>
</p>
<hr />
<h3 class="h3">Introduction
</h3>
<p>The Toxicology Section performs analyses on biological samples (e.g., blood, urine, liver) to determine the absence/presence/concentration(s) of drugs, including alcohol and poisons.
</p>
<p>This document is intended as a convenient investigative reference but should not be relied upon as definitive or exhaustive. Please contact the Centre of Forensic Sciences (CFS) Toxicology Section for assistance with questions of an analytical or toxicological nature by e-mail or telephone 647-329-1400 or 647-329-1430. When calling please ask for the appropriate coordinator:
</p>
<p>Coroner’s Coordinator:<br />
	<a href="mailto:CFSToxicologyCoronerCoordinator@ontario.ca">CFSToxicologyCoronerCoordinator@ontario.ca</a>
</p>
<p>Criminal Coordinator:<br />
	<a href="mailto:toxcrim@ontario.ca">toxcrim@ontario.ca</a>
</p>
<h3 class="h3">Examination Strategy and Capability
</h3>
<p>The screening methods employed in the Toxicology Section are:
</p>
<ol>
	<li style="margin-left: 36pt;">Gas Chromatography (GC) and Gas Chromatography/Mass Spectrometry (GC/MS)
	</li>
	<li style="margin-left: 36pt;">Immunoassay (IA)
	</li>
	<li style="margin-left: 36pt;">Head-Space GC analysis for volatiles
	</li>
	<li style="margin-left: 36pt;">Quadrupole Time-of-Flight MS (QTOF)
	</li>
</ol>
<p>The targeted/quantitation methods employed in the Toxicology Section are:
</p>
<ol>
	<li style="margin-left: 36pt;">GC, GC/MS
	</li>
	<li style="margin-left: 36pt;">Liquid Chromatography (LC), LC-MS/MS
	</li>
	<li style="margin-left: 36pt;">Head-Space GC analysis for volatiles
	</li>
</ol>
<p>Capabilities of screening methods are presented in Appendix 1. While these screening methods have wide-ranging capabilities not all drugs may be reliably detected. Appendix 2 contains a list of compounds that may not be identified by the screening methods but may be detected/quantitated by targeted methods. Many of the compounds contained in this list will not be tested for unless specifically requested. If use of a specific drug is known or suspected and is relevant it should be noted in the case synopsis.
</p>
<p>The examination strategy, i.e., determining which tests will be performed in a case, is informed by a variety of sources including case type, case history, nature of submitted samples, analytical protocols and capabilities, and discussions with clients. The initial toxicological analyses conducted for a variety of case types are presented in Appendix 3.
</p>
<h3 class="h3">Urgent Cases
</h3>
<p>Requests for expedited analyses must meet specific criteria before being accepted as an urgent case. This process requires authorization by Toxicology Section management.
</p>
<h3 class="h3">Examination
</h3>
<p>All items are visually examined on receipt to check the seal numbers (if present), the contents, and the integrity of the packaging.
</p>
<h3 class="h3">Instrumentation
</h3>
<h4 class="h4">Chromatography: Gas Chromatography (GC); Liquid Chromatography (LC)
</h4>
<p>Chromatography is an analytical technique used to separate compounds based on their chemical and structural properties. GC uses a pressurized gas, while LC uses a pressurized liquid, in the separation of compounds.
</p>
<h4 class="h4">Immunoassay (IA)
</h4>
<p>IA detects compounds in biological fluids using a reaction of an antibody or antibodies to its antigen (i.e., the drug). This technique is primarily a screening technique; however, some IA methods are semi-quantitative, e.g., acetaminophen.
</p>
<h4 class="h4">Mass Spectrometry (MS)
</h4>
<p>MS detects, identifies, and quantitates compounds. An MS can be coupled with a GC or an LC.
</p>
<h4 class="h4">Quadrupole Time-of-Flight-MS (QTOF)
</h4>
<p>QTOF detects and identifies compounds. A QTOF is coupled with an LC.
</p>
<h4 class="h4">Tandem MS (MS/MS)
</h4>
<p>MS/MS detects, identifies, and quantitates compounds and is commonly coupled to a gas or liquid chromatograph.
</p>
<h4 class="h4">Ultraviolet and Visible (UV/VIS) Spectrophotometry
</h4>
<p>UV/VIS spectrophotometry identifies and/or quantitates a drug based on its UV and/or visible light-absorbing properties.
</p>
<h4 class="h4">Carbon Monoxide
</h4>
<p>Carbon monoxide is analyzed by visible spectrophotometry. Results are expressed as % carboxyhemoglobin saturation.
</p>
<h3 class="h3">Interpretation
</h3>
<p>Quantitative results may be expressed as 1) a concentration or 2) as &lt; or &gt; a concentration, e.g., when sufficient for interpretation. Blood ethanol interpretations provided in reports are generally limited to cases in which the detected concentration may be associated with fatalities, may be influenced by post-mortem artefacts, may have toxic interactions with other drugs, or in the case of motor vehicle collision, associated with impairment.
</p>
<h3 class="h3">Measurement Uncertainty
</h3>
<p>Measurements made with all scientific instruments are associated with variability. No measurement is exact but is an estimate of the true value. Calculation of measurement uncertainty (MU) employs statistical methods to determine the range of values within which the quantitative result is likely to reside. The MU provides a reasonable estimate of the variability associated with the analytical method and is based on the analysis of matrix-matched quality control samples. A minimum of 10 such analyses are used. The MU is calculated with a confidence of 95.45 per cent using a k-factor based on the degrees of freedom as determined by the Student’s <cite>t</cite>-test and the standard deviation of the associated quality control data. The MU is expressed in the same units in which the quantitative result is reported, e.g., ng/mL, mg/L and is reported as: quantitative result ± MU.
</p>
<h3 class="h3">Limitations
</h3>
<p>The focus of this laboratory is drug toxicity. Clinical blood/urine chemistry analysis, e.g., electrolytes, cell counts, gas saturation, creatinine, is not performed. Analysis for antiepileptic drugs is limited to determining drug toxicity, when warranted, based on case history. This laboratory does not have validated methods to analyze some sample types, e.g., oral fluid, hair, bile, muscle, brain tissue. There are a variety of analytical issues that may prevent the detection of some of the drugs that this laboratory is commonly capable of detecting, which include:
</p>
<ul>
	<li style="margin-left: 54pt;">matrix effects
	</li>
	<li style="margin-left: 108pt;">degree of putrefaction
	</li>
	<li style="margin-left: 108pt;">type of sample (e.g., splenic blood)
	</li>
	<li style="margin-left: 108pt;">post-mortem interval
	</li>
	<li style="margin-left: 108pt;">storage conditions
	</li>
	<li style="margin-left: 54pt;">volume of sample submitted
	</li>
	<li style="margin-left: 54pt;">low concentration of the drug/sensitivity of the method
	</li>
</ul>
<p>Conversely, some novel, or rarely encountered, drugs not listed in Appendix 1 may be identified by the GC and GC/MS or QTOF screens. In this case, analytical reference material would be acquired (if available) then analysed to confirm identity. There are drugs/compounds for which the CFS Toxicology Section does not have a method, examples of which are provided in Appendix 4.
</p>
<hr />
<h3 class="h3">Appendix 1 – Screening Methods
</h3>
<p>Drugs that can be reliably detected by screening methods.
</p>
<h4 class="h4"><abbr title="Gas Chromatography">GC</abbr> and <abbr title="Gas Chromatography">GC</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Screen
</h4>
<div class="col-md-6">
	<p><strong>A</strong><br />
		alpha-pyrrolidinovalerophenone (α-PVP)<br />
		acetyl fentanyl<sup>2</sup><br />
		amantadine<sup>1</sup><br />
		amitriptyline<sup>2</sup><br />
		amlodipine<sup>2</sup><br />
		amoxapine<sup>2</sup><br />
		amphetamine<sup>2</sup><br />
		amphetamine (4-fluoro)<br />
		amphetamine (dimethyl)<br />
		anabasine<br />
		anileridine<sup>1</sup><br />
		atomoxetine<br />
		atropine/hyoscyamine
	</p>
	<p><strong>B</strong><br />
		benzocaine<br />
		benzofuran (6-(2-aminopropyl, 6-APB)<br />
		benztropine<sup>1</sup><br />
		benzylpiperazine (BZP)<br />
		bromo-dragonfly<br />
		brompheniramine<sup>2</sup><br />
		bupivacaine<sup>1</sup><br />
		bupropion<sup>2</sup><br />
		butylone<br />
		butyryl fentanyl
	</p>
	<p><strong>C</strong><br />
		caffeine<sup>1</sup><br />
		carbamazepine<sup>2</sup><br />
		cathinone (cath)<br />
		n-ethyl-cath<br />
		4-flurometh-cath<br />
		3-methoxymeth-cath<br />
		4-methyleth-cath<br />
		meth-cath<br />
		chlorcyclizine<br />
		chlordiazepoxide<sup>2</sup><br />
		chloroquine<br />
		chlorpheniramine<sup>2</sup><br />
		chlorpromazine<sup>1</sup><br />
		cimetidine<br />
		cisapride<sup>4</sup><br />
		citalopram*<sup>2</sup><br />
		clomipramine<sup>2</sup><br />
		clonidine<sup>1</sup><br />
		clozapine<sup>2</sup><br />
		cocaethylene<br />
		cocaine<sup>2</sup><br />
		codeine<sup>2</sup><br />
		cotinine<br />
		cyclobenzaprine<sup>2</sup><br />
		cyproheptadine<sup>1</sup>
	</p>
	<p><strong>D</strong><br />
		desipramine<sup>2</sup><br />
		dextromethorphan<sup>2</sup><br />
		dextrorphan*<br />
		diazepam<sup>2</sup><br />
		diazepam (nor)<sup>2</sup><br />
		dibucaine<sup>4</sup><br />
		dihydrocodeine<br />
		diltiazem<sup>2</sup><br />
		diltiazem (desacetyl)<sup>2</sup><br />
		dimethyltryptamine<br />
		diphenhydramine<sup>2</sup><br />
		diphenoxylate<sup>1</sup><br />
		doxepin<sup>2</sup><br />
		doxylamine<sup>2</sup>
	</p>
	<p><strong>E</strong><br />
		ephedrine*<br />
		estazolam<br />
		etizolam<sup>2</sup><br />
		ethylone
	</p>
	<p><strong>F</strong><br />
		<cite>x</cite>-fluoroamphetamine<br />
		fluoxetine<sup>2</sup><br />
		fluoxetine (nor)<sup>2</sup><br />
		flurazepam<sup>2</sup><br />
		flurazepam (n-desalkyl)<sup>2</sup><br />
		fluvoxamine<sup>2</sup>
	</p>
	<p><strong>H</strong><br />
		haloperidol<sup>1</sup><br />
		hydrocodone<sup>2</sup><br />
		hydroxychloroquine<br />
		hydroxyzine<sup>1</sup>
	</p>
	<p><strong>I</strong><br />
		ibogaine<br />
		imipramine<sup>2</sup>
	</p>
	<p><br />
		<strong>K</strong><br />
		ketamine<sup>2</sup>
	</p>
	<p><strong>L</strong><br />
		lamotrigine<sup>2</sup><br />
		laudanosine<br />
		levamisole<br />
		lidocaine<br />
		loratadine<br />
		loxapine<sup>2</sup>
	</p>
</div>
<div class="col-md-6">
	<p><strong>M</strong><br />
		maprotiline<sup>1</sup><br />
		meclizine<sup>1</sup><br />
		mefloquine<sup>1</sup><br />
		meperidine<sup>2</sup><br />
		meperidine (nor)<sup>2</sup><br />
		mephedrone<sup>2</sup><br />
		mepivacaine<sup>1</sup><br />
		methadone<sup>2</sup><br />
		methamphetamine<sup>2</sup><br />
		methamphetamine (4-fluoro)<br />
		methedrone<br />
		methotrimeprazine<sup>2</sup><br />
		methylenedioxyamphetamine (MDA)<sup>2</sup><br />
		methylenedioxyethylamphetamine (MDEA)<sup>2</sup><br />
		methylenedioxymethamphetamine (MDMA)<sup>2</sup><br />
		3,4-methylenedioxypyrovalerone (MDPV)<sup>2</sup><br />
		methylone<sup>2</sup><br />
		methylphenidate<sup>2</sup><br />
		metoclopramide<sup>1</sup><br />
		metoprolol<sup>2</sup><br />
		midazolam<sup>2</sup><br />
		mirtazapine<sup>2</sup><br />
		moclobemide<sup>1</sup>
	</p>
	<p><strong>N</strong><br />
		nicotine<sup>1</sup><br />
		nortriptyline<sup>2</sup>
	</p>
	<p><strong>O</strong><br />
		olanzapine<sup>2</sup><br />
		orphenadrine<sup>2</sup><br />
		oxybutynin<sup>1</sup><br />
		oxycodone<sup>2</sup>
	</p>
	<p><strong>P</strong><br />
		paroxetine<sup>2</sup><br />
		pentadrone<br />
		pentazocine<sup>2</sup><br />
		pentoxyphylline<sup>2</sup><br />
		pentylone<br />
		phenacetin<br />
		phencyclidine (PCP)<sup>2</sup><br />
		phenethylamines (2C-B, 2C-B-Fly, 2C-T-7, PEA)<br />
		pheniramine<sup>2</sup><br />
		phenmetrazine<br />
		phentermine<sup>1</sup><br />
		piperazine, 1-3 chlorophenyl (mCPP)<br />
		piperazine, trifluoromethylphenyl (TFMPP)<br />
		p-fluorofentanyl<br />
		p-methoxyamphetamine (PMA)<sup>2</sup><br />
		p-methoxymeth-amphetamine (PMMA)<br />
		procainamide<sup>1</sup><br />
		procaine<sup>1</sup><br />
		prochlorperazine<sup>2</sup><br />
		procyclidine<sup>1</sup><br />
		propoxur<sup>1</sup><br />
		propoxyphene<sup>2</sup><br />
		propranolol<sup>2</sup><br />
		protriptyline<sup>2</sup><br />
		pseudoephedrine<sup>2</sup><br />
		pyrilamine (mepyramine)<sup>1</sup>
	</p>
	<p><strong>Q</strong><br />
		quetiapine<sup>2</sup><br />
		quinidine<sup>1</sup>
	</p>
	<p><strong>R</strong><br />
		ropinirole<br />
		ropivacaine
	</p>
	<p><strong>S</strong><br />
		scopolamine (hyoscine)<sup>1</sup><br />
		selegiline<br />
		sertraline<sup>2</sup><br />
		strychnine<sup>1</sup>
	</p>
	<p><strong>T</strong><br />
		tapentadol<br />
		terbinafine<br />
		thioridazine<sup>1</sup><br />
		ticlopidine<br />
		tramadol<sup>2</sup><br />
		tranylcypromine<sup>1</sup><br />
		trazodone<sup>2</sup><br />
		trifluoperazine<sup>1</sup><br />
		trihexphenidyl<sup>2</sup><br />
		trimethoprim<sup>4</sup><br />
		trimebutine<br />
		trimipramine<sup>2</sup><br />
		triprolidine<sup>2</sup>
	</p>
	<p><strong>V</strong><br />
		valeryl fentanyl<br />
		varenicline<br />
		venlafaxine<sup>2</sup><br />
		venlafaxine (O-desmethyl)<sup>2</sup><br />
		verapamil<sup>2</sup>
	</p>
	<p><strong>X</strong><br />
		xylometazoline
	</p>
	<p><strong>Z</strong><br />
		zolpidem<sup>2</sup><br />
		zopiclone breakdown product
	</p>
</div>
<p>The <abbr title="Gas Chromatography">GC</abbr> and <abbr title="Gas Chromatography">GC</abbr>/<abbr title="Mass Spectrometry">MS</abbr> screen is not capable of distinguishing racemates, therefore compounds such as dextrorphan/levorphanol, citalopram/escitalopram and ephedrine/pseudoephedrine cannot be separated. Similarly, the <abbr title="Gas Chromatography">GC</abbr> and <abbr title="Gas Chromatography">GC</abbr>/<abbr title="Mass Spectrometry">MS</abbr> screen cannot distinguish between 2-fluoroamphetamine, 3-fluoroamphetamine, and 4-fluoroamphetamine.
</p>
<h4 class="h4"><abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen
</h4>
<p>The <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> screen is a powerful and sensitive method that can reliably detect the drugs included in the following methods (details are listed in Appendices 5 and 6):
</p>
<ul>
	<li><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 2
	</li>
	<li><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3 (except carfentanil)
	</li>
	<li><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 4
	</li>
	<li><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 5 (except: diflunisal, furosemide, ibuprofen, salicylate, vigabatrin)
	</li>
</ul>
<p>In addition, the <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> screen can identify psilocin. The list of drugs potentially identifiable by <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> is too extensive to list within this document. For questions about a specific drug not listed, please contact the appropriate <a href="#_Analytical_Decision-making_and">case coordinator</a>.
</p>
<h4 class="h4">Immunoassay tests (known cross-reactivity)
</h4>
<p class="normal"><strong>Barbiturates:</strong>
</p>
<p>amobarbital<sup>2</sup><br />
	butalbital<sup>2</sup><br />
	pentobarbital<sup>2</sup><br />
	phenobarbital<sup>2</sup><br />
	secobarbital<sup>2</sup>
</p>
<p><strong>Head-space <abbr title="Gas Chromatography">GC</abbr>-FID analysis for volatiles (screen and quantitation)</strong>
</p>
<p>acetone<br />
	ethanol<br />
	isopropanol<br />
	methanol<br />
	n-propanol (not quantitated)
</p>
<p><strong>Volatile screen (qualitative only)</strong>
</p>
<p>difluoroethane<br />
	dichloromethane<br />
	1,1,1,2-tetrafluoroethane<br />
	ethyl acetate<br />
	diethyl ether<br />
	dimethyl ether<br />
	propane<br />
	butane<br />
	isobutane<br />
	toluene<br />
	methanol<br />
	ethanol<br />
	acetone<br />
	methyl ethyl ketone<br />
	isopropyl alcohol<br />
	acetaldehyde<br />
	chloroform<br />
	gasoline
</p>
<hr />
<h3 class="h3">Appendix 2 – Drugs requiring targeted analysis
</h3>
<p>Compounds that may not be identified by screening methods but might be detected and/or quantitated by targeted methods.
</p>
<div class="col-md-6">
	<p class="normal"><strong>A</strong><br />
		acepromazine<sup>4</sup><br />
		amiloride<sup>4</sup><br />
		antipyrine (phenazone)<sup>1</sup><br />
		atracurium<sup>4</sup><br />
		azacyclonol<sup>4</sup>
	</p>
	<p class="normal"><strong>B</strong><br />
		bromocriptine<sup>4</sup>
	</p>
	<p class="normal"><strong>C</strong>
	</p>
	<p>carbaryl<sup>1</sup><br />
		carbon monoxide<sup>6</sup><br />
		<br />
		<br />
		chlorzoxazone<sup>4</sup><br />
		cyanide<sup>2</sup>
	</p>
	<p class="normal"><strong>D</strong><br />
		dantrolene<sup>4</sup><br />
		<br />
		<br />
		diflunisal<sup>2</sup><br />
		dipyridamole<sup>4</sup>
	</p>
	<p class="normal"><strong>E</strong><br />
		ethopropazine<sup>4</sup><br />
		ethylene glycol<sup>7</sup>
	</p>
	<p><strong>F</strong><br />
		fenfluramine<sup>1</sup><br />
		fenodipine<sup>4</sup><br />
		fenoprofen<sup>4</sup><br />
		formic acid<sup>5</sup><br />
		furosemide<sup>2</sup>
	</p>
	<p class="normal"><strong>I</strong><br />
		ibuprofen<sup>2</sup><br />
		indomethacin<sup>4</sup>
	</p>
	<p class="normal"><strong>K</strong><br />
		ketoconazole<sup>4</sup>
	</p>
</div>
<div class="col-md-6">
	<p class="normal"><strong>M</strong><br />
		mefenamic acid<sup>4</sup><br />
		methaqualone<sup>1</sup><br />
		<br />
		<br />
		metronidazole<sup>4</sup><br />
		mexiletine<sup>1</sup>
	</p>
	<p class="normal"><strong>N</strong><br />
		nabumetone<sup>4</sup>
	</p>
	<p class="normal"><strong>O</strong><br />
		oxprenolol<sup>4</sup>
	</p>
	<p class="normal"><strong>P</strong><br />
		<br />
		<br />
		pericyazine<sup>4</sup><br />
		phenylbutazone<sup>4</sup><br />
		phenyltoloxamine<sup>1</sup><br />
		physostigmine<sup>1</sup><br />
		pimozide<sup>4</sup><br />
		pindolol<sup>4</sup><br />
		pipotiazine<sup>4</sup><br />
		piroxicam<sup>4</sup><br />
		prazosin<sup>4</sup>
	</p>
	<p class="normal"><strong>S</strong><br />
		<br />
		sotalol<sup>4</sup><br />
		sufentanil<sup>1</sup>
	</p>
	<p class="normal"><strong>T</strong><br />
		terazosin<sup>4</sup><br />
		terfenadine<sup>4</sup><br />
		tiaprofenate<sup>4</sup><br />
		timolol<sup>4</sup><br />
		tolbutamide<sup>4</sup><br />
		toluene<sup>5</sup><br />
		triamterene<sup>4</sup>
	</p>
	<p class="normal"><strong>V</strong>
	</p>
	<p>valproic acid<sup>5</sup><br />
		vigabatrin<sup>2</sup>
	</p>
	<p class="normal"><strong>Y</strong><br />
		yohimbine<sup>4</sup>
	</p>
</div>
<p>
</p>
<p>Methods used for the quantitation of compounds identified in the preceding appendices are denoted as follows: <br />
	<sup>1 </sup><abbr title="Gas Chromatography">GC</abbr>-NPD<br />
	<sup>2</sup> <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr><br />
	<sup>4</sup> <abbr title="Liquid Chromatography">LC</abbr>-DAD<br />
	<sup>5</sup> <abbr title="Gas Chromatography">GC</abbr>-FID<br />
	<sup>6</sup> Visible spectrophotometry<br />
	<sup>7</sup> Qualitative
</p>
<hr />
<h3 class="h3">Appendix 3 – Initial analyses by case type
</h3>
<p><strong>Alcohol-impaired driving: </strong>Ethanol
</p>
<p><strong>Attempted murder<sup>a</sup>: </strong>dependent upon case history
</p>
<p><strong>Confirmation of ketoacidosis: </strong>Ethanol (includes acetone), BHB
</p>
<p><strong>Death of child &lt; 5 years of age </strong>Ethanol, <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3, <abbr title="Immunoassay">IA</abbr> cannabinoids, <abbr title="Immunoassay">IA</abbr> acetaminophen and salicylate
</p>
<p><strong>Drug-impaired driving: </strong><abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Immunoassay">IA</abbr> cannabinoids, UDM, GHB<sup>a</sup>
</p>
<p><strong>Fatal motor vehicle collision (driver) and aviation death:</strong> Ethanol, <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3, <abbr title="Immunoassay">IA</abbr> cannabinoids, CO<sup>c</sup>
</p>
<p><strong>Fire-related death<sup>b</sup>: </strong>CO (whole blood required)
</p>
<p><strong>Homicide: </strong>Ethanol, <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3, <abbr title="Immunoassay">IA</abbr> cannabinoids
</p>
<p><strong>Mandatory inquest:</strong> Ethanol, <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3, <abbr title="Immunoassay">IA</abbr> cannabinoids
</p>
<p><strong>Possible drug-related death: </strong>Ethanol, <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3
</p>
<p><strong>Rule Out/exclusionary Toxicology: </strong>Ethanol, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3
</p>
<p><strong>Sexual assault<sup>a</sup>: </strong>dependent upon case history
</p>
<p><strong>SIU death investigation: </strong>Ethanol, <abbr title="Quadrupole Time-of-Flight">QTOF</abbr> Screen, <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3, <abbr title="Immunoassay">IA</abbr> cannabinoids<br />
	 
</p>
<p><sup>a </sup>dependent upon case history<br />
	<sup>b </sup>other analyses may be performed dependent upon evidence/suspicion of intoxication<br />
	<sup>c </sup>if fire is involved
</p>
<hr />
<h3 class="h3">Appendix 4 – No method available
</h3>
<p class="normal"><strong>Animal toxins</strong><br />
	a-bungarotoxin<br />
	conotoxin<br />
	maurotoxin<br />
	tetrodotoxin
</p>
<p><strong>Anesthetic gases</strong><br />
	halothane<br />
	isoflurane<br />
	nitrous oxide<br />
	 
</p>
<p><strong>Curare-related toxins</strong><br />
	alloferine<br />
	toxiferine<br />
	tubocurarine
</p>
<p><strong>Other</strong><br />
	insulin<br />
	lead, mercury<br />
	lithium<br />
	polychlorinated biphenyls (PCB)<br />
	succinylcholine<br />
	thallium<br />
	xylazine
</p>
<hr />
<h3 class="h3">Appendix 5 – Capability of Quantitative Methods
</h3>
<div class="col-md-6">
	<p><strong>Barbiturate method (<abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr>)</strong><br />
		amobarbital (qualitative)<br />
		butalbital<br />
		pentobarbital<br />
		phenobarbital<br />
		phenytoin<br />
		primidone<br />
		secobarbital
	</p>
	<p><strong>GHB/BHB method (<abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr>)</strong><br />
		g-hydroxybutyrate (GHB)<br />
		β-hydroxybutyrate (BHB)
	</p>
	<p><strong><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 2</strong><br />
		brompheniramine<br />
		ephedrine<br />
		phenylephrine<br />
		trimeprazine<br />
		triprolidine
	</p>
	<p><strong><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 3</strong><br />
		6-monoacetylmorphine (6-MAM; qualitative)<br />
		Alprazolam<br />
		Amitriptyline<br />
		Amphetamine<br />
		Benzoylecgonine<br />
		Bupropion<br />
		carfentanil<br />
		chlorpheniramine<br />
		citalopram/escitalopram<br />
		<br />
		<br />
		clonazepam<br />
		clonazepam (7-amino; qualitative)<br />
		cocaine<br />
		codeine<br />
		cyclobenzaprine<br />
		dextromethorphan<br />
		diazepam<br />
		diazepam (nor)<br />
		diphenhydramine<br />
		fentanyl<br />
		flunitrazepam (7-amino)<br />
		fluoxetine<br />
		fluoxetine (nor)<br />
		flurazepam (n-desalkyl)<br />
		hydrocodone<br />
		hydromorphone<br />
		ketamine<br />
		ketamine (nor)<br />
		lorazepam<br />
		meperidine<br />
		meperidine (nor)<br />
		mephedrone<br />
		methadone<br />
		methamphetamine<br />
		methylenedioxyamphetamine<br />
		methylenedioxyethylamphetamine<br />
		methylenedioxymethamphetamine<br />
		midazolam<br />
		mirtazapine<br />
		morphine<br />
		nortriptyline<br />
		olanzapine<br />
		oxazepam<br />
		oxycodone<br />
		oxymorphone<br />
		paroxetine<br />
		pseudoephedrine<br />
		quetiapine<br />
		risperidone<br />
		sertraline<br />
		temazepam<br />
		tramadol (cis)<br />
		trazodone<br />
		venlafaxine<br />
		zopiclone
	</p>
</div>
<div class="col-md-6">
	<p><strong><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 4</strong>
	</p>
	<p>acetyl fentanyl<br />
		alprazolam (hydroxyl)<br />
		amoxapine<br />
		bromazepam<br />
		buprenorphine<br />
		butyryl fentanyl<br />
		chlordiazepoxide<br />
		chlorpromazine<br />
		clobazam<br />
		clomipramine<br />
		clozapine<br />
		demoxepam<br />
		desipramine<br />
		desomorphine<br />
		diltiazem<br />
		diltiazem (desacetyl)<br />
		doxepin<br />
		doxylamine<br />
		duloxetine<br />
		etizolam<br />
		flunitrazepam<br />
		flunitrazepam (N-desmethyl)<br />
		flurazepam<br />
		fluvoxamine<br />
		furanyl fentanyl<br />
		imipramine<br />
		levorphanol/dextrorphan (qualitative)<br />
		loxapine<br />
		MDPV<br />
		methotrimeprazine<br />
		methylone<br />
		methylphenidate<br />
		naloxone<br />
		naltrexone<br />
		nitrazepam<br />
		nitrazepam (7-amino)<br />
		O-desmethylvenlafaxine<br />
		orphenadrine<br />
		PCP<br />
		pentazocine<br />
		pheniramine<br />
		promethazine<br />
		propoxyphene<br />
		triazolam<br />
		triazolam (hydroxy)<br />
		trimipramine<br />
		U-47700<br />
		ziprasidone<br />
		zolpidem
	</p>
	<p><strong><abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr> Mix 5</strong><br />
		acebutolol<br />
		acetaminophen<br />
		amiodarone<br />
		amlodipine<br />
		atenolol<br />
		baclofen<br />
		carbamazepine (qualitative)<br />
		<br />
		<br />
		diflunisal<br />
		furosemide<br />
		gabapentin<br />
		guaifenesin<br />
		pregabalin<br />
		ibuprofen<br />
		labetolol<br />
		lamotrigine<br />
		methocarbamol<br />
		metoprolol<br />
		naproxen<br />
		<br />
		<br />
		prochlorperazine<br />
		propafenone<br />
		propranolol<br />
		pseudoephedrine<br />
		salicylate<br />
		topiramate<br />
		verapamil<br />
		vigabatrin
	</p>
	<p><strong>Cannabinoid method (<abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr>)</strong><br />
		tetrahydrocannabinol (THC)<br />
		11-nor-carboxytetrahydrocannabinol (Carboxy-THC)<br />
		11-hydroxytetrahydrocannabinol (11-OH-THC, qualitative)<br />
		cannabidiol<br />
		cannabinol
	</p>
	<p><strong>Digoxin method (<abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr>)</strong><br />
		digoxin<br />
		digitoxin (qualitative)
	</p>
</div>
<hr />
<h3 class="h3">Appendix 6 – Capability of targeted qualitative methods
</h3>
<div class="col-md-6">
	<p class="normal"><strong>Urine Drug Mix (UDM; <abbr title="Liquid Chromatography">LC</abbr>-<abbr title="Mass Spectrometry">MS</abbr>/<abbr title="Mass Spectrometry">MS</abbr>)</strong>6-monoacetylmorphine (6-MAM)<br />
		acetylfentanyl<br />
		acetylnorfentanyl<br />
		alprazolam<br />
		amitriptyline<br />
		amlodipine<br />
		amoxapine<br />
		amphetamine<br />
		baclofen<br />
		benzoylecgonine<br />
		bromazepam<br />
		brompheniramine<br />
		buprenorphine<br />
		buprenorphine glucuronide<br />
		bupropion<br />
		butyryl fentanyl<br />
		carfentanil<br />
		chlordiazepoxide<br />
		chlorpheniramine<br />
		citalopram<br />
		clobazam<br />
		clomipramine<br />
		clonazepam<br />
		clonazepam (7-amino)<br />
		clozapine<br />
		cocaethylene<br />
		cocaine<br />
		codeine<br />
		codeine-6-glucuronide<br />
		cyclobenzaprine<br />
		demoxepam<br />
		desipramine<br />
		desomorphine<br />
		dextromethorphan<br />
		diazepam<br />
		diazepam (nor)<br />
		diltiazem<br />
		diltiazem (desacetyl)<br />
		diphenhydramine<br />
		doxepin<br />
		doxylamine<br />
		duloxetine<br />
		ephedrine<br />
		etizolam<br />
		fentanyl<br />
		fentanyl (nor)<br />
		flualprazolam<br />
		flubromazolam<br />
		flunitrazepam<br />
		flunitrazepam (7-amino)<br />
		flunitrazepam (N-desmethyl)<br />
		fluoxetine<br />
		fluoxetine (nor)<br />
		flurazepam<br />
		flurazepam (n-desalkyl)<br />
		fluvoxamine<br />
		furanyl fentanyl<br />
		gabapentin<br />
		heroin<br />
		hydrocodone<br />
		hydromorphone<br />
		hydromorphone-3-glucuronide<br />
		hydroxyalprazolam<br />
		hydroxytriazolam<br />
		imipramine<br />
		ketamine<br />
		ketamine (nor)
	</p>
</div>
<div class="col-md-6">
	<p><br />
		<br />
		lamotrigine<br />
		levorphanol/dextrorphan<br />
		lidocaine<br />
		lorazepam<br />
		lorazepam glucuronide<br />
		loxapinemeperidine<br />
		meperidine (nor)<br />
		mephedrone<br />
		methadone<br />
		methamphetamine<br />
		methylenedioxyamphetamine<br />
		methylenedioxyethylamphetamine<br />
		methylenedioxymethamphetamine<br />
		methylenedioxypyrovalerone<br />
		methylone<br />
		methylphenidate<br />
		metoprolol<br />
		midazolam<br />
		mirtazapine<br />
		morphine<br />
		morphine-3-glucuronide<br />
		morphine-6-glucuronide<br />
		naloxone<br />
		naltrexone<br />
		nitrazepam<br />
		nitrazepam (7-amino)<br />
		nortriptyline<br />
		O-desmethylvenlafaxine<br />
		olanzapine<br />
		orphenadrine<br />
		oxazepam<br />
		oxazepam glucuronide<br />
		oxycodone<br />
		oxymorphone<br />
		paroxetine<br />
		pentazocine<br />
		phenazepam<br />
		phencyclidine<br />
		pheniramine<br />
		pregabalin<br />
		propoxyphene<br />
		propranolol<br />
		pseudoephedrine<br />
		quetiapine<br />
		risperidone<br />
		sertraline<br />
		tapentadol<br />
		temazepam<br />
		temazepam glucuronide<br />
		THC-COOH glucuronide<br />
		THC-COOH<br />
		topiramate<br />
		tramadol (cis)<br />
		trazodone<br />
		triazolam<br />
		trimipramine<br />
		U-47700<br />
		venlafaxine<br />
		zaleplon<br />
		ziprasidone<br />
		zolpidem<br />
		zopiclone
	</p>
</div>
<hr />
<h3 class="h3">Glossary
</h3>
<p><strong>Abbreviations</strong><br />
	Analytical results are reported in terms of mg/100 mL, mg/L, or ng/mL, as shown below:
</p>
<p>g - gram<br />
	mg - milligram<br />
	µg - microgram<br />
	L - litre<br />
	mL - millilitre<br />
	ng - nanogram
</p>
<p><strong>Breakdown Product</strong><br />
	A compound produced either inside or outside the body that may or may not be pharmacologically active.
</p>
<p><strong>Carboxyhemoglobin saturation</strong><br />
	The percentage of hemoglobin bound by carbon monoxide.
</p>
<p><strong>Central Nervous System Depression (CNS depression)</strong><br />
	A lowering of the functional activity of the brain and/or spinal cord. Depression of the respiratory and the cardio-regulatory centres are most relevant toxicologically.
</p>
<p><strong>Confirmation</strong><br />
	The process of verifying the presence of a drug by replicate analysis using the same or different analytical technique(s). Confirmation of an immunoassay result is achieved using a more specific analytical technique.
</p>
<p><strong>Coroner's Case Analytical Summary</strong><br />
	Contains analytical results with the fatal reference and limitations. The Coroner’s Case Analytical Summary is accompanied by an Interpretive Guide with information specific to this report type.
</p>
<p><strong>Detected</strong><br />
	The drug has been identified in the sample. Identification is based on criteria specific to the analytical technique.
</p>
<p><strong>Fatal Reference</strong><br />
	A minimum drug concentration at which death has been reliably reported in the forensic literature.
</p>
<p><strong>Inconclusive</strong><br />
	The presence or absence of a drug could not be determined.
</p>
<p><strong>Metabolite</strong><br />
	The product of enzymatic conversion of a drug within the body to a different compound that may or may not be pharmacologically active.
</p>
<p><strong>No [other] significant findings by a [method name(s)]</strong><br />
	This comment is inserted to provide a reference to the methods that were used. Appendices 1 and 5 above can be used to identify compounds not listed and that were either not detected or the results were deemed to not be toxicologically significant, <abbr title="for example">e.g.</abbr>, caffeine or nicotine. This may also apply to endogenous compounds, <abbr title="for example">e.g.</abbr>, acetone &lt; 2 mg/100 mL.
</p>
<p><strong>Not Detected</strong><br />
	The drug is either not present or is present but at an amount that cannot be discerned from other constituents in the sample.
</p>
<p><strong>Post-mortem redistribution</strong><br />
	A phenomenon that refers to a change (either an increase or a decrease) in blood drug concentration after death; post-mortem redistribution may occur regardless of sampling site but is commonly observed as increased drug concentrations in heart blood as compared to femoral blood.
</p>
<p><strong>Putrefaction</strong><br />
	The decomposition of organic material that involves micro-organisms.
</p>
<p><strong>Report</strong><br />
	Contains a comprehensive summary of analytical results accompanied by interpretative conclusions.
</p>
<p><strong>Tentative</strong><br />
	A drug has been identified by a screening method but has not been confirmed. Where a non-specific screening method, <abbr title="for example">e.g.</abbr>, immunoassay, produces a tentative result, further analysis would be required to positively identify the compound.
</p>
<p><strong>Therapeutic</strong><br />
	The detected drug concentration is generally considered to not be toxicologically significant. The use of this term does not imply clinical efficacy.
</p>
<p><strong>Traces</strong><br />
	The drug was detected at a concentration below that which can be reliably quantitated. The use of this term does not imply clinical efficacy.
</p></div></div></div></section>  </div>
											</div>
				</main>
			</section>
		</div>		
		<div class="column sidebar col-md-3 col-md-pull-9 zero-pad-right">
									<div class="cx-navbar-collapse collapse navbar-collapse" id="left_wrapper_menu">
			<section id="mcscs-main-menu" class="block block-menu contextual-links-region clearfix">	<div class="photocap nav_top grey"></div>		<div class="menu-wrapper"><h2 class="block-title"><a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/CFS_tech_sheets.html" class="menu-title-wrapper">Technical information sheets</a></h2></div><div class="collapse in">	<ul class="sub-menu-block"><li class="first"><a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Biology/CFS_bio_tech.html" class="" role="button" data-block-id="#mcscs-submenu-15483">Biology</a></li>
<li class=""><a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Chemistry/CFS_chem_tech.html" class="" role="button" data-block-id="#mcscs-submenu-15484">Chemistry</a></li>
<li class=""><a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Documents/CFS_docs_tech.html" class="" role="button" data-block-id="#mcscs-submenu-15485">Documents</a></li>
<li class=""><a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/FirearmsToolmarks/CFS_fire_tool_tech.html" class="" role="button" data-block-id="#mcscs-submenu-15486">Firearms and Toolmarks</a></li>
<li class="oactive expanded"><a href="/english/centre_forensic/InformationforInvestigatorsSubmitters/TechnicalInformationSheets/Toxicology/CFS_tox_tech.html" class="submenu-toggle1 active" role="button" data-block-id="#mcscs-submenu-15487">Toxicology</a><ul id="mcscs-submenu-15487" class="sub-menu"></ul>
</li>
<li class=""><a href="/english/CentreForensicSciences/Technicalinformationsheets/CFSReportingexaminationresultsandopinions.html" class="" role="button" data-block-id="#mcscs-submenu-18899">Reporting of examination results and opinions</a></li>
</ul>
</div></section>			
						
							<div class="cx-navbar-collapse margin-top">
					<nav class="sidebar-first">
						  <div class="region region-sidebar-first">
    
<section id="block-menu-menu-contacts" class="block block-menu clearfix">
				<div class="photocap nav_top grey"></div>
		<div class="menu-wrapper">
			<h2  class="block-title">
				<a role="button" href="#link-block-menu-menu-contacts" aria-expanded="false" aria-controls="link-block-menu-menu-contacts" data-toggle="collapse">
					<span class="menu-title-wrapper">Contacts</span>
				</a>
			</h2>
		</div>
			<div id="link-block-menu-menu-contacts" class="collapse ">
		<ul class="sub-menu-block"><li class="first leaf"><a href="http://www.infogo.gov.on.ca/infogo/searchDirectory.do?actionType=changeLocale&amp;locale=en">Telephone Directory</a></li>
<li class="leaf"><a href="http://www.ontario.ca/serviceontario">Service Ontario</a></li>
<li class="last leaf"><a href="https://www.ola.org/en/members/current">MPPs</a></li>
</ul>	</div>
</section>
<section id="block-menu-menu-additional-resources" class="block block-menu clearfix">
				<div class="photocap nav_top grey"></div>
		<div class="menu-wrapper">
			<h2  class="block-title">
				<a role="button" href="#link-block-menu-menu-additional-resources" aria-expanded="false" aria-controls="link-block-menu-menu-additional-resources" data-toggle="collapse">
					<span class="menu-title-wrapper">Additional Resources</span>
				</a>
			</h2>
		</div>
			<div id="link-block-menu-menu-additional-resources" class="collapse ">
		<ul class="sub-menu-block add-res"><li class="first leaf"><a href="http://www.slasto.gov.on.ca/en/ocpc/Pages/default.aspx" id="link-ocpc">Ontario Civilian Police Commission</a></li>
<li class="leaf"><a href="http://policearbitration.on.ca/?lang=en" id="link-opac">Ontario Police Arbitration Commission</a></li>
<li class="last leaf"><a href="http://www.slasto.gov.on.ca/en/opb/Pages/default.aspx" id="link-opb">Ontario Parole Board</a></li>
</ul>	</div>
</section>  </div>
					</nav> 
				</div>
						
						</div>
		</div>
	</div>
</div>
<div class="container">
	<div class="row">
		<div class="col-md-12">
			<div class="footer-border"></div>
		</div>
		<footer class="footer region-footer">
			<div class="col-md-6">
				<h2 class="accessible">Site Help</h2><!-- Invisible header DO NOT EDIT OR REMOVE -->
				<ul>
					<li>
						<a href="/english/contact_us/contact_us.aspx">Contact Us</a>
					</li>
					<li>
						<a href="http://www.ontario.ca/government/accessibility">Accessibility</a>
					</li>
					<li>
						<a href="http://www.ontario.ca/government/privacy-statement">Privacy</a>
					</li>
					<li>
						<a href="/english/sitemap/sitemap.html">Site Map</a>
					</li>
				</ul>
			</div>
			<div class="col-md-6">
				<h2 class="accessible">Notices</h2><!-- Invisible header DO NOT EDIT OR REMOVE -->
				<ul class="right">
					<li>
						<a title="Site copyright" href="http://www.ontario.ca/government/copyright-information-c-queens-printer-ontario">&copy; Queen's Printer for Ontario, </a>
					</li>
					<li>
						<a href="http://www.ontario.ca/government/terms-use">Terms of Use</a>
					</li>
				</ul>
			</div>
			<div class="col-md-12">
				<p class="last-mod">
											- Last Modified: December 21, 2020									</p>
			</div>
		</footer>
	</div>
</div>		<script src="/sites/all/themes/bootstrap/js/bootstrap.js?"></script>
		<script type="text/javascript" src="/sites/all/themes/bootstrap/js/gametrics.js"></script>
		<script type="text/javascript">window.twttr = (function (d, s, id) { var t, js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) return; js = d.createElement(s); js.id = id; js.src= "https://platform.twitter.com/widgets.js"; fjs.parentNode.insertBefore(js, fjs); return window.twttr || (t = { _e: [], ready: function (f) { t._e.push(f) } }); }(document, "script", "twitter-wjs")); </script>
	</body>
</html>